Immune function in severe, active rheumatoid arthritis. A relationship between peripheral blood mononuclear cell proliferation to soluble antigens and synovial tissue immunohistologic characteristics.
about
Activation pathways of synovial T lymphocytes. Expression and function of the UM4D4/CDw60 antigen.Thymus-dependent and -independent regulation of Ia antigen expression in situ by cells in the synovium of rats with streptococcal cell wall-induced arthritis. Differences in site and intensity of expression in euthymic, athymic, and cyclosporin A-trStudies of T-cell activation in chronic inflammation.Interleukin-1beta (IL-1beta) inhibition: a possible mechanism for the anti-inflammatory potency of liposomally conjugated methotrexate formulations in arthritis.Absence of peripheral blood T cell responses to "shared epitope' containing peptides in recent onset rheumatoid arthritis.Soluble adhesion molecules (ICAM-1, VCAM-1, and E-selectin) and vascular endothelial growth factor (VEGF) in patients with distinct variants of rheumatoid synovitis.Low circulating soluble interleukin 2 receptor level predicts rapid response in patients with refractory rheumatoid arthritis treated with infliximab.Basis for defective proliferation of peripheral blood T cells to anti-CD2 antibodies in primary Sjögren's syndrome.Hyperplastic synoviocytes from rats with streptococcal cell wall-induced arthritis exhibit a transformed phenotype that is thymic-dependent and retinoid inhibitable.Nodular alteration of the paracortical area. An in situ immunohistochemical analysis of primary, secondary, and tertiary T-nodules.Recent developments in the immunobiology of rheumatoid arthritisActivation of macrophages in an experimental rat model of arthritis induced by Erysipelothrix rhusiopathiae infectionFDG PET for rheumatoid arthritis: basic considerations and whole-body PET/CT.Applications of monoclonal antibodies to the in situ detection of human leucocytes.Effects of continuously administered murine interleukin-1 alpha: tolerance development and granuloma formation.Interleukin 3 stimulates proliferation and triggers endothelial-leukocyte adhesion molecule 1 gene activation of human endothelial cells.T cell receptor beta gene polymorphism and rheumatoid arthritis.Characteristics of immunocompetent cells in synovial membranes from multiple sites in patients with rheumatoid arthritis.Recognition of self class II major histocompatibility complex antigens by CD8+ T cell clones derived from rheumatoid arthritis synovial membrane.Expanded Primary T Nodules in the Palatine Tonsils from Patients with IgA Nephropathy
P2860
Q34261505-221EE734-B89C-46BB-A8C3-757FBFB06DFAQ34567361-1A076ADC-095F-4EB9-B4E9-EAF1396EA52AQ34731209-A6176890-9C92-4FB0-B0E5-11A31BE9AF1FQ35041474-64A96425-F319-4357-9FCD-5FA5C4A83E44Q35547225-24376B5E-F363-49FD-B50D-981CE9F6A5B1Q35551876-9D86710D-74F8-440C-AF84-ED4F1BA52E9FQ35636544-788D00DE-ABEF-41D7-B9B8-E9EDB6FE69BAQ35817196-09C71323-C3EA-4572-8AA9-F4D08DAB3727Q35818533-9FD37377-6AFD-46B4-9E5B-38C115586100Q35835256-6472CA7C-4501-48BE-B608-5BBC787CFEDBQ36757047-48E7CB7A-6E7D-4D72-8CFF-7146D5A31456Q37025151-BC6A39E9-407A-4CF6-A033-F2BBE545BE5AQ37896132-99CFE920-970E-48C4-A268-E622227D6E21Q39479827-8B304ED9-249D-4ED0-BD5A-880FE7AE9D22Q40428015-FB7F9E3E-7C34-4E5A-8A6E-027519BA3B84Q41021848-43F5084C-E88D-4FBA-AA10-C7B6E0C3470BQ41089801-640EF1D2-4F86-4AF0-AA10-8A3E965AEF0EQ41253563-E6B971DE-FE51-4ECE-9207-659C86A3044AQ46336606-654C70CD-B892-46E8-B0A0-629AC46C0E9FQ58078911-F2034867-4BA2-433D-AFE3-0E6A0FCBC397
P2860
Immune function in severe, active rheumatoid arthritis. A relationship between peripheral blood mononuclear cell proliferation to soluble antigens and synovial tissue immunohistologic characteristics.
description
1984 nî lūn-bûn
@nan
1984 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1984 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
1984年の論文
@ja
1984年論文
@yue
1984年論文
@zh-hant
1984年論文
@zh-hk
1984年論文
@zh-mo
1984年論文
@zh-tw
1984年论文
@wuu
name
Immune function in severe, act ...... unohistologic characteristics.
@ast
Immune function in severe, act ...... unohistologic characteristics.
@en
Immune function in severe, act ...... unohistologic characteristics.
@nl
type
label
Immune function in severe, act ...... unohistologic characteristics.
@ast
Immune function in severe, act ...... unohistologic characteristics.
@en
Immune function in severe, act ...... unohistologic characteristics.
@nl
prefLabel
Immune function in severe, act ...... unohistologic characteristics.
@ast
Immune function in severe, act ...... unohistologic characteristics.
@en
Immune function in severe, act ...... unohistologic characteristics.
@nl
P2093
P2860
P356
P1476
Immune function in severe, act ...... unohistologic characteristics.
@en
P2093
P2860
P304
P356
10.1172/JCI111526
P407
P577
1984-10-01T00:00:00Z